WallStSmart
ANL

Adlai Nortye Ltd. American Depositary Shares

NASDAQ: ANL · HEALTHCARE · BIOTECHNOLOGY

$13.15
-9.55% today

Updated 2026-06-05

Market cap
$725.12M
P/E ratio
P/S ratio
145.02x
EPS (TTM)
$-1.11
Dividend yield
52W range
$1 – $17
Volume
0.4M

Adlai Nortye Ltd. American Depositary Shares (ANL) Financial statements

SEC filings — annual and quarterly data.

Profit margin
-710.56%
Operating margin
-713.96%
ROE
-414.00%
ROA
-42.20%
Debt/equity
-3.17x

Margin trends — annual

Gross margin Operating margin Profit margin
YearRevenueNet incomeGross marginOp. marginProfit margin
2019$-17.83M
2020$-63.38M
2021$45.73M$-56.68M100.00%-18.91%-123.95%
2022$0.00$-58.79M
2023$5.00M$-109.23M100.09%-1,452.28%-2,186.46%
2024$0.00$-51.87M
2025$5.00M$-35.53M100.00%-713.96%-710.56%

Frequently asked questions

What is Adlai Nortye Ltd. American Depositary Shares's revenue?

Adlai Nortye Ltd. American Depositary Shares's trailing twelve-month revenue is $5.00M. Revenue is the top line the whole model builds on, and at this scale the question shifts from how fast it grows to whether margins hold as it compounds.

How profitable is ANL?

In its most recent fiscal year, ANL ran a gross margin of 100.00%, an operating margin of -713.96%, and a net margin of -710.56%. Margins this high mean most of each extra dollar of revenue drops through to profit, which is the signature of real pricing power.

How much free cash flow does ANL generate?

ANL produced $-33.73M in free cash flow in its most recent fiscal year. Free cash flow is what is left after running and reinvesting in the business, and it is the cash that actually funds buybacks, dividends, and a stronger balance sheet.

Is ANL's balance sheet healthy?

ANL holds $23.79M in cash and equivalents against — in long-term debt, on $-8.32M of shareholder equity. That debt is best read against the cash flow the business throws off each year.